1.
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-...
by Poulter, Neil R
The Lancet (British edition), 2005, Vol.366 (9489), p.907-913
2.
Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
by Tan, Kathryn C. B
Diabetologia, 2018, Vol.61 (5), p.1212-1219
3.
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
by Zalcman, Gérard, Prof
The Lancet (British edition), 2015, Vol.387 (10026), p.1405-1414
4.
Productive performance and blood profiles of laying hens fed Hermetia illucens larvae meal as total replacement of soybean meal from 24 to 45 weeks of age
by Marono, S
Poultry science, 2017, Vol.96 (6), p.1783-1790
5.
Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial
by Pimenta, Eduardo
Hypertension (Dallas, Tex. 1979), 2009, Vol.54 (3), p.475-481
6.
Acute kidney injury in decompensated cirrhosis
by Tsien, Cynthia D
Gut, 2013, Vol.62 (1), p.131-137
7.
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
by Mann, Johannes FE, Prof
The Lancet (British edition), 2008, Vol.372 (9638), p.547-553
8.
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension
by Rhodes, Christopher J
Heart (British Cardiac Society), 2011, Vol.97 (13), p.1054-1060
9.
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
by Davis, T. M. E
Diabetologia, 2010, Vol.54 (2), p.280-290
10.
Beat-to-Beat, Reading-to-Reading, and Day-to-Day Blood Pressure Variability in Relation to Organ Damage in Untreated Chinese
by Wei, Fang-Fei
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (4), p.790-796
11.
Association Studies Suggest a Key Role for Endothelin-1 in the Pathogenesis of Preeclampsia and the Accompanying Renin-Angiotensin-Aldosterone System Suppression
by Verdonk, Koen
Hypertension (Dallas, Tex. 1979), 2015, Vol.65 (6), p.1316-U274
12.
Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM)
by Ronco, Claudio, Dr
The Lancet (British edition), 2014, Vol.383 (9931), p.1807-1813
13.
Endogenous markers for kidney function in children: a review
by den Bakker, Emil
Critical reviews in clinical laboratory sciences, 2018, Vol.55 (3), p.163-183
14.
Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension: Six-Month Results From the Prague-15 Study
by Rosa, Ján
Hypertension (Dallas, Tex. 1979), 2015, Vol.65 (2), p.407-413
15.
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
by Vaidya, Vishal S
Nature biotechnology, 2010, Vol.28 (5), p.478-485
16.
Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial
by Brar, Somjot S, Dr
The Lancet (British edition), 2014, Vol.383 (9931), p.1814-1823
17.
Early recognition and prevention of chronic kidney disease
by James, Matthew T, MD
The Lancet (British edition), 2010, Vol.375 (9722), p.1296-1309
18.
Acute Kidney Injury Reduces Survival in Very Low Birth Weight Infants
by KORALKAR, Rajesh
Pediatric research, 2011, Vol.69 (4), p.354-358
19.
Follow-up of Acute kidney injury in Neonates during Childhood Years (FANCY): a prospective cohort study
by Harer, Matthew W
Pediatric nephrology (Berlin, West), 2017, Vol.32 (6), p.1067-1076
20.
